Researchers' perspectives on methodological challenges and outcomes selection in interventional studies targeting medication adherence in rheumatic diseases: an OMERACT-adherence study.
Medication adherence
Qualitative research
Rheumatology
Journal
BMC rheumatology
ISSN: 2520-1026
Titre abrégé: BMC Rheumatol
Pays: England
ID NLM: 101738571
Informations de publication
Date de publication:
08 Jul 2021
08 Jul 2021
Historique:
received:
21
10
2020
accepted:
09
04
2021
entrez:
8
7
2021
pubmed:
9
7
2021
medline:
9
7
2021
Statut:
epublish
Résumé
Research on adherence interventions in rheumatology is limited by methodological issues, particularly heterogeneous outcomes. We aimed to describe researchers' experiences with conducting interventional studies targeting medication adherence in rheumatology and their perspectives on establishing core outcomes. Semi-structured interviews using audio conference were conducted with researchers who had conducted an adherence study of any design in the past 10 years. Data collection and thematic analysis were performed iteratively, until saturation. We interviewed 13 researchers, most of whom worked in academia and specialized in epidemiology and/or health services research. We identified three themes: 1) improving measurement of adherence (considering all phases of adherence, using appropriate and relevant measures, and establishing clinically meaningful thresholds); 2) challenges in designing and appraising adherence intervention studies (considering the confusion over a plethora of outcomes, difficulties with powering studies to demonstrate meaningful changes, and suboptimal descriptions of adherence interventions in published studies); and 3) advancing outcome assessment in adherence intervention studies (capturing rationale for developing a core domain set as well as recommendations and anticipated challenges by participants). Uniquely gathering perspectives from international adherence researchers, our findings led to researcher-informed recommendations for improving adherence research including specifying the targeted adherence phase in designing interventions and studies and providing a glossary of terms to promote consistency in reporting. We also identified recommendations for developing a core domain set for interventional studies targeting medication adherence including involvement of patients, clinicians, and other stakeholders and methodological and practical considerations to establish rigor and support uptake.
Sections du résumé
BACKGROUND
BACKGROUND
Research on adherence interventions in rheumatology is limited by methodological issues, particularly heterogeneous outcomes. We aimed to describe researchers' experiences with conducting interventional studies targeting medication adherence in rheumatology and their perspectives on establishing core outcomes.
METHODS
METHODS
Semi-structured interviews using audio conference were conducted with researchers who had conducted an adherence study of any design in the past 10 years. Data collection and thematic analysis were performed iteratively, until saturation.
RESULTS
RESULTS
We interviewed 13 researchers, most of whom worked in academia and specialized in epidemiology and/or health services research. We identified three themes: 1) improving measurement of adherence (considering all phases of adherence, using appropriate and relevant measures, and establishing clinically meaningful thresholds); 2) challenges in designing and appraising adherence intervention studies (considering the confusion over a plethora of outcomes, difficulties with powering studies to demonstrate meaningful changes, and suboptimal descriptions of adherence interventions in published studies); and 3) advancing outcome assessment in adherence intervention studies (capturing rationale for developing a core domain set as well as recommendations and anticipated challenges by participants).
CONCLUSIONS
CONCLUSIONS
Uniquely gathering perspectives from international adherence researchers, our findings led to researcher-informed recommendations for improving adherence research including specifying the targeted adherence phase in designing interventions and studies and providing a glossary of terms to promote consistency in reporting. We also identified recommendations for developing a core domain set for interventional studies targeting medication adherence including involvement of patients, clinicians, and other stakeholders and methodological and practical considerations to establish rigor and support uptake.
Identifiants
pubmed: 34233761
doi: 10.1186/s41927-021-00193-4
pii: 10.1186/s41927-021-00193-4
pmc: PMC8265120
doi:
Types de publication
Journal Article
Langues
eng
Pagination
26Références
Curr Med Res Opin. 2009 Sep;25(9):2303-10
pubmed: 19635045
Br J Clin Pharmacol. 2012 May;73(5):691-705
pubmed: 22486599
Arthritis Res Ther. 2015 Oct 08;17:281
pubmed: 26449852
Ann Behav Med. 2014 Aug;48(1):7-16
pubmed: 24500078
Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1437-1441
pubmed: 28994158
Trials. 2018 Mar 27;19(1):204
pubmed: 29587864
Value Health. 2008 Jan-Feb;11(1):44-7
pubmed: 18237359
Cochrane Database Syst Rev. 2014 Nov 20;(11):CD000011
pubmed: 25412402
J Rheumatol. 2020 Oct 1;47(10):1565-1574
pubmed: 31839595
Arthritis Care Res (Hoboken). 2014 Oct;66(10):1551-9
pubmed: 24692321
Arthritis Care Res (Hoboken). 2017 Nov;69(11):1706-1713
pubmed: 28086003
Arthritis Care Res (Hoboken). 2021 May;73(5):702-706
pubmed: 31961497
Arthritis Care Res (Hoboken). 2015 Dec;67(12):1712-21
pubmed: 26097166
Nurse Educ Today. 2004 Feb;24(2):105-12
pubmed: 14769454
Curr Med Res Opin. 2009 Jul;25(7):1711-9
pubmed: 19485724
Ann Intern Med. 2018 Jul 3;169(1):30-35
pubmed: 29946690
Health Educ Q. 1984 Spring;11(1):1-47
pubmed: 6392204
Biomed Res Int. 2015;2015:217047
pubmed: 26539470
J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S79-87
pubmed: 17133207
Ann Rheum Dis. 2016 Apr;75(4):667-73
pubmed: 25667208
Ci Ji Yi Xue Za Zhi. 2019 Apr-Jun;31(2):73-80
pubmed: 31007485